Publicacions en què col·labora amb JOSÉ LUIS PABLOS ÁLVAREZ (13)

2020

  1. Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence

    Cells, Vol. 9, Núm. 12

2018

  1. Inhibitory role of growth hormone in the induction and progression phases of collagen-induced arthritis

    Frontiers in Immunology, Vol. 9, Núm. MAY

2014

  1. VIP modulates IL-22R1 expression and prevents the contribution of rheumatoid synovial fibroblasts to IL-22-mediated joint destruction

    Journal of Molecular Neuroscience, Vol. 52, Núm. 1, pp. 10-17

2013

  1. IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts

    Rheumatology (United Kingdom), Vol. 52, Núm. 12, pp. 2177-2186

  2. Inflammatory mediators alter interleukin-17 receptor, interleukin-12 and -23 expression in human osteoarthritic and rheumatoid arthritis synovial fibroblasts: Immunomodulation by vasoactive intestinal peptide

    NeuroImmunoModulation, Vol. 20, Núm. 5, pp. 274-284

2011

  1. Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: Effect of vasoactive intestinal peptide

    Journal of Cellular Physiology, Vol. 226, Núm. 12, pp. 3261-3269

  2. RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: Immune regulation by vasoactive intestinal peptide

    Arthritis and Rheumatism, Vol. 63, Núm. 6, pp. 1626-1636

2008

  1. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1086-1095

  2. Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: Implications for rheumatoid arthritis

    Brain, Behavior, and Immunity, Vol. 22, Núm. 3, pp. 312-317

  3. VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts

    Molecular Immunology, Vol. 45, Núm. 11, pp. 3065-3073

2006

  1. VIP decreases TLR4 expression induced by LPS and TNF-α treatment in human synovial fibroblasts

    Annals of the New York Academy of Sciences

  2. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts

    Rheumatology, Vol. 45, Núm. 5, pp. 527-532

2004

  1. Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells

    Rheumatology, Vol. 43, Núm. 4, pp. 416-422